Announcing the winner of our research image contest, identifying a new source of symptoms for autism spectrum disorder and the opening of the new Ataxia Center.
Dear Mass General Research Community,
We've all faced setbacks in the course of our scientific careers.
What motivates you to keep going during those long days and nights in thelab? When an experiment fails? When a paper gets rejected or your grant application gets a low score?
Is it scientific curiosity? Wanting to make a difference? A personal story or connection? A determination to solve a key problem in disease? Finding ways to improve patient care?
Keeping your "why" in mind will help sustain you through the inevitable peaks and valleys of your career. It's also a great way to connect with colleagues, donors and the general public.
So, what's your science "why"?
Let us know in 100 words or less by sending an email to email@example.com. The more we can talk about you, our scientists, and why you do your research here at Mass General, the better. (And, you just might get some movie tickets for your time!)
Susan A. Slaugenhaupt, PhD Scientific Director, Mass General Research Institute
Research Institute Image Contest: Meet the Winner!
The second annual Mass General Research Institute Image contest winner was chosen from 46 images submitted by researchers from 15 centers and departments at Massachusetts General Hospital.
We started the Image Contest last year to encourage researchers to share their work with the world, and we could not be happier with the results. We have received attention from people across the globe and our finalists were featured in STAT Morning Rounds.
Adam Viens, fromthe Mansour Lab within the Division of Infectious Diseases, took first place with his image titled "Neutrophil Attack!" This image captured the moment a mouse neutrophil recognized and started to engulf a pathogenic fungus.
Lauren Orefice, PhD, a new faculty member in the Department of Molecular Biology, was recently named the grand prize winner of the Eppendorf & Science Prize for Neurobiology for her work identifying peripheral sensory neurons as a contributing factor to touch overreactivity in autism spectrum disorder (ASD).
Orefice, who completed the work as a postdoctoral fellow in the Ginty Lab at Harvard Medical School, is now continuing her research at Mass General with the hope of finding new treatments for patients with ASD.
Ataxia is a degenerative disease of the nervous system that results from damage to the cerebellum. Jeremy Schmahmann, MD, has been a pioneer in cerebellar ataxia clinical care and research for over 35 years.
In 1994 he founded the Massachusetts General Hospital Ataxia Unit, the first clinic of its kind to focus exclusively on disorders of the cerebellum.
In recognition of its 25th anniversary, Schmahmann is launching the Massachusetts General Hospital Ataxia Center, which seeks to provide comprehensive, personalized and patient-centered care for those with ataxia.